NEVRO CORP. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 11 rows in 2018. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-11-27: Reporting owner Christoforou Christofer; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2018-11-27: Reporting owner Schmitz Patrick; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2018-11-27: Reporting owner Alleavitch Doug; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2018-11-27: Reporting owner Rashid Kashif; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-11-27 | Christoforou Christofer Officer (VP, Research & Development) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +11,000 11,000 owned after | $42.30 exercise price | 2018-11-29 | |
| 2018-11-27 | Schmitz Patrick Officer (Vice President, Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,500 16,500 owned after | $42.30 exercise price | 2018-11-29 | |
| 2018-11-27 | Alleavitch Doug Officer (VP, Quality) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,500 16,500 owned after | $42.30 exercise price | 2018-11-29 | |
| 2018-11-27 | Rashid Kashif Officer (General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +32,500 32,500 owned after | $42.30 exercise price | 2018-11-29 | |
| 2018-09-17 | Elghandour Rami Director, Officer (President & CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −18,400 101,146 owned after | $3.60 exercise price | 2018-09-19 | |
| 2018-08-01 | Alleavitch Doug Officer (VP, Quality) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 34,000 owned after | $53.70 exercise price | 2018-08-03 | |
| 2018-07-25 | Alleavitch Doug Officer (VP, Quality) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,500 35,000 owned after | $53.70 exercise price | 2018-07-26 | |
| 2018-07-18 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,400 11,004 owned after | $1.44 exercise price | 2018-07-20 | |
| 2018-05-14 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,000 21,463 owned after | $18.00 exercise price | 2018-05-16 | |
| 2018-05-11 | DEMANE MICHAEL F Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,631 80,291 owned after | $18.00 exercise price | 2018-05-15 | |
| 2018-03-01 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,000 28,463 owned after | $18.00 exercise price | 2018-03-05 |